Latest Strategic Pivot News

NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.

Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.

Embelton Limited has reported a solid 20.4% increase in revenue and a 34.7% jump in profit after tax for FY2026, underpinned by a strategic pivot away from residential construction towards infrastructure and social sectors. The company held its dividend steady amid improving cash flow and reduced borrowings.

XPON Technologies (ASX: XPN) posted a $1.1 million positive EBITDA in FY26 on 38% revenue growth, shedding Alpha Digital and selling its Google Marketing business to focus on its Wondaris AI platform.

Pacific Resources Limited (ASX: PXR) completed a strategic pivot in FY2026, acquiring the high-grade Snowstorm Gold Project in Victoria and expanding exploration in Tasmania, while maintaining its Queensland coal assets. The company reported a $769K loss on no operating revenue, supported by a $1.5 million capital raise.

Xenitra Limited has secured A$1.5 million through a discounted share placement to accelerate growth in higher-margin OTC medicines, FSMP, and tokenised FMCG sales. The capital will fund inventory expansion, supplier fulfilment, and ecommerce activation as the company shifts from low-margin distribution to a diversified healthcare platform.

WT Financial Group (ASX: WTL) delivered its sixth consecutive year of growth in FY2026, with net profit before tax up 19% to $6.55 million and a fully franked final dividend declared at 0.75 cents per share. The company also completed a strategic disposal of its B2C subsidiaries, advancing its Hubco investment model.

hipages Group lifted FY26 revenue 9% to $90.6 million and expanded EBITDA margin to a record 25.3%, driven by strong subscription ARPU growth and AI-powered platform enhancements. The Group also acquired a majority stake in Viz Insurance and launched a 10% on-market share buy-back.

Nuix posted a robust FY26 with 18.8% revenue growth and a 179% jump in Nuix Neo ACV, driving a 60% rise in core EBITDA. The company’s strategic pivot to platform value and AI integration sets the stage for continued expansion.

Mitchell Services (ASX:MSV) posted a strong FY26 with revenue up 5% to A$207.4 million and EBITDA surging 67% to A$42.8 million. The company returned to a net cash position of A$3.5 million and declared a fully franked 2 cent dividend, reflecting robust operational execution and a strategic pivot towards gold.

Cash Converters posted 11% revenue growth in FY26 driven by franchise acquisitions and loan book evolution, while net profit fell 20% amid strategic shifts and one-off costs.

Li-S Energy reported a reduced net loss of $4.9 million in FY26, propelled by major technological advances and a $7.8 million ARENA grant to scale manufacturing. The company secured key regulatory approvals and expanded strategic defence partnerships, positioning itself at the forefront of sovereign lithium sulfur battery supply.